LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Guillain-Barré syndrome and COVID-19: association or coincidence.

    Gale, Aislinn / Sabaretnam, Suganya / Lewinsohn, Asher

    BMJ case reports

    2020  Volume 13, Issue 11

    Abstract: ... uncertainty or error.We present a patient who attended hospital with features of Guillain-Barré syndrome (GBS ... COVID-19 is a novel disease best known to cause a cough, fever and respiratory failure. Recently ... before developing clinical and radiological findings of COVID-19. While the authors recognise that neurological ...

    Abstract COVID-19 is a novel disease best known to cause a cough, fever and respiratory failure. Recently, it has been recognised that COVID-19 may present in multi-systemic ways which can cause diagnostic uncertainty or error.We present a patient who attended hospital with features of Guillain-Barré syndrome (GBS) before developing clinical and radiological findings of COVID-19. While the authors recognise that neurological complications have been reported following COVID-19 infection, to their knowledge this report describes a unique presentation of GBS without preceding COVID-19 symptoms.Since these conditions may have considerable overlapping features including respiratory failure and (following prolonged critical care admission) profound weakness, it is possible that one diagnosis may be overlooked. Raising awareness of a possible association between these conditions is important so both are considered allowing appropriate investigations to be arranged to optimise the chance of neurological recovery and survival, while also protecting staff from potentially unrecognised COVID-19.
    MeSH term(s) COVID-19/diagnosis ; COVID-19/physiopathology ; COVID-19/prevention & control ; COVID-19/therapy ; Comorbidity ; Critical Illness/rehabilitation ; Critical Illness/therapy ; Diagnostic Errors/prevention & control ; Guillain-Barre Syndrome/diagnosis ; Guillain-Barre Syndrome/physiopathology ; Guillain-Barre Syndrome/therapy ; Humans ; Infection Control/methods ; Male ; Middle Aged ; Neurologic Examination/methods ; Patient Care Management/methods ; Pneumonia, Viral/diagnostic imaging ; Pneumonia, Viral/virology ; Respiration, Artificial/methods ; Respiratory Insufficiency/diagnosis ; Respiratory Insufficiency/etiology ; SARS-CoV-2/isolation & purification ; Tomography, X-Ray Computed/methods ; Treatment Outcome
    Language English
    Publishing date 2020-11-30
    Publishing country England
    Document type Case Reports ; Journal Article
    ISSN 1757-790X
    ISSN (online) 1757-790X
    DOI 10.1136/bcr-2020-239241
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Guillain-Barré Syndrome Associated with COVID-19: Is There A Causal Relation or Just A Coincidence?

    Şirin, Nermin Görkem

    Noro psikiyatri arsivi

    2023  Volume 60, Issue 4, Page(s) 295–297

    Abstract: ... of Guillain-Barré syndrome (GBS) associated with COVID-19 have been published to unravel the possible causal link between GBS ... not. The clinical features of GBS associated with COVID-19 was older age, male predominance, and ... After the outbreak of Coronavirus disease 19 (COVID-19), several case reports and case series ...

    Abstract After the outbreak of Coronavirus disease 19 (COVID-19), several case reports and case series of Guillain-Barré syndrome (GBS) associated with COVID-19 have been published to unravel the possible causal link between GBS and COVID-19. In this brief report, the epidemiological data from regions in different countries was reviewed. Some studies report an increase in the incidence of GBS during the pandemic while the others do not. The clinical features of GBS associated with COVID-19 was older age, male predominance, and typical sensorimotor variant responding well to treatments. The most common electrodiagnostic subtype was demyelinating. Despite the high effort, the causal relation between COVID-19 and GBS remains controversial. Case-control studies with high number of patients are needed to understand the relation between GBS and COVID-19.
    Language English
    Publishing date 2023-11-16
    Publishing country Turkey
    Document type Editorial
    ZDB-ID 2565770-7
    ISSN 1300-0667
    ISSN 1300-0667
    DOI 10.29399/npa.28547
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Guillain-Barré syndrome associated with Covid-19: A close relationship or just a coincidence? (Review).

    Stoian, Adina / Bălașa, Rodica / Grigorescu, Bianca Liana / Maier, Smaranda / Andone, Sebastian / Cocuz, Iuliu Gabriel / Bajko, Zoltan / Filep, Cristian Rares / Stoian, Mircea

    Experimental and therapeutic medicine

    2021  Volume 22, Issue 3, Page(s) 916

    Abstract: ... hypercoagulability and direct neurotropism of the virus are thought to be involved. Guillain-Barré syndrome is ... this viral infection and the occurrence of Guillain-Barré syndrome. The main mechanism of Guillain-Barré syndrome is ... characteristics and disease evolution seem to be similar to those observed in Guillain-Barré syndrome secondary ...

    Abstract Several neurological complications affecting the central and peripheral nervous system were described secondary to COVID-19 infection such as hyposmia, headache, nausea, impaired consciousness, psychosis, neurocognitive syndromes and even cerebrovascular accidents. The mechanism of these complications is not fully understood, but heterogenous mechanisms such as cytokine storm, secondary hypercoagulability and direct neurotropism of the virus are thought to be involved. Guillain-Barré syndrome is a heterogeneous disease that frequently follows a bacterial or viral infection. During the ongoing SARS-CoV-2 pandemic, several isolated case reports and case series have suggested an association between this viral infection and the occurrence of Guillain-Barré syndrome. The main mechanism of Guillain-Barré syndrome is probably post-viral dysregulation of the immune system generated by SARS-CoV-2. The clinical characteristics and disease evolution seem to be similar to those observed in Guillain-Barré syndrome secondary to other etiologies. The aim of the present review is to summarize the relevant literature regarding SARS-CoV-2-related Guillain-Barré syndrome.
    Language English
    Publishing date 2021-06-29
    Publishing country Greece
    Document type Journal Article ; Review
    ZDB-ID 2683844-8
    ISSN 1792-1015 ; 1792-0981
    ISSN (online) 1792-1015
    ISSN 1792-0981
    DOI 10.3892/etm.2021.10348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Covid-19 Infection Complicated by Guillain-barré Syndrome: a Case Report

    Bueso, T. / Elmassry, M. / El Nawaa, S. E. N. / Ball, S. / Solis, X. / Test, V.

    Chest

    Abstract: ... Guillain Barre syndrome associated with COVID-19 infection: A case report J Clin Neurosci, 2020 Reference #2: 2 Zhao, H ... et al , Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence ... Guillain-Barre syndrome: More than a coincidence! Rev Neurol (Paris), 2020 DISCLOSURES: No relevant relationships ...

    Abstract SESSION TITLE: Medical Student/Resident Chest Infections Posters SESSION TYPE: Med Student/Res Case Rep Postr PRESENTED ON: October 18-21, 2020 INTRODUCTION: COVID-19 (SARS-CoV-2) is causing a current pandemic It commonly manifests with fever, dyspnea, and cough Few COVID-19 patients with Guillain-Barré Syndrome (GBS) have been reported The severe inflammatory response and the critically-ill nature of many COVID-19 patients is a challenge to distinguish GBS from critical illness polyneuropathy and myopathy We present a COVID-19 patient complicated by GBS CASE PRESENTATION: A 60-year-old woman presented with fever, cough, myalgia, and dyspnea for 10 days A swab for SARS-CoV-2 RT-PCR was positive CT chest revealed bilateral “ground-glass” opacities She was started on oxygen, azithromycin, and hydroxychloroquine Three weeks later, she developed bilateral symmetrical LE numbness and weakness that progressed to UE Respiratory status worsened with increasing O2 requirements Neuro exam showed weakness (2/5) in LE and (3/5) in UE Respiratory muscle testing demonstrated a NIF of -35 cm H2O and an FVC of 1 7 L MRI spine showed contrast enhancement of cauda equina nerve roots (Fig 1) CSF analysis revealed cytoalbuminologic dissociation (CAD) with 197 mg/dL of proteins and 0 WBC She was diagnosed with GBS and started on intravenous immunoglobulin (IVIG) 0 4g/Kg/day for 5 days After a week of therapy, the patient improved, recovered from COVID-19, and was discharged home DISCUSSION: GBS is a disorder in which the immune system attacks gangliosides on the peripheral nervous system It presents with ascending weakness and can cause total body paralysis and respiratory failure in severe cases It is associated with a variety of viral and bacterial infections 12 cases of GBS have been reported in COVID-19 infection GBS developed within 10 days of COVID diagnosis and presented with ascending progressive, flaccid quadriparesis All except 2 patients underwent CSF analysis and 91% showed CAD IVIG was used for all the patients, and one was started on plasmapheresis The involvement of the PNS supports the coronavirus neurotropic invasion pathway It is still unclear if SARS-CoV-2 can directly invade neurons and cause neuropathy We could not test for SARS-CoV-2 in CSF in our case, but the absence of WBC in the CSF indicated an immune response typically seen in GBS rather than direct neuronal invasion, in which pleocytosis is expected MRI usually showed contrast enhancement of cauda-equina nerve roots due to radicular irritation CSF showing CAD is usually observed in the second week after symptom onset IVIG is preferred over plasmapheresis for treating GBS due to fewer side effects However, thrombotic events occur in 1–16 9% All of the reported COVID-19 cases with GBS, including our case, received IVIG, and none of them reported thrombotic events CONCLUSIONS: Our case emphasizes that GBS should be considered as one of the differentials in patients with COVID-19 patients with ARDS, polyneuropathy, and difficulty weaning off ventilator Reference #1: 1 Sedaghat, Z and N Karimi, Guillain Barre syndrome associated with COVID-19 infection: A case report J Clin Neurosci, 2020 Reference #2: 2 Zhao, H , et al , Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol, 2020 19(5): p 383-384 Reference #3: 3 El Otmani, H , et al , Covid-19 and Guillain-Barre syndrome: More than a coincidence! Rev Neurol (Paris), 2020 DISCLOSURES: No relevant relationships by Somedeb Ball, source=Web Response No relevant relationships by Tulio Bueso, source=Web Response No relevant relationships by Saif El Naser El Nawaa, source=Web Response No relevant relationships by Mohamed Elmassry, source=Web Response No relevant relationships by Ximena Solis, source=Web Response No relevant relationships by Victor Test, source=Web Response
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #860851
    Database COVID19

    Kategorien

To top